IRT leadership Cenduit is the leading IRT systems specialist with global reach, extensive study startup capabilities, and RTSM, patient engagement, and materials forecasting services. This positions them as a strong partner for sponsors needing end-to-end trial randomization, supply management, and rapid study initiation.

Global reach With over 500 experts across the US, UK, Switzerland, India, Japan and China and trial experience in more than 100 countries across 32,000 sites, there is a substantial opportunity to engage multinational trials and complex global studies requiring standardized IRT and RTSM platforms.

Financial scale Reported revenue of 50M–100M and a client base that includes large CROs and pharma players suggest there is room to pursue expanded contracts, upsell on platform modules, and longer-term maintenance and support commitments to grow wallet share.

Product maturity Frequent platform updates and module expansions since 2014 indicate a mature, evolving product roadmap with potential for cross-sell of new drug management, simulation, forecasting, and integration capabilities to complement existing IRT deployments.

Strategic fit Existing tech stack and focus on integration, data management, and clinical operations align with sponsors seeking standardized, scalable IT services; there is opportunity to position Cenduit as the backbone for large, tech-enabled trials and digital patient engagement initiatives.